Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tubulin-specific chaperone E (TBCE) is a critical protein involved in the folding and dimerization of alpha- and beta-tubulin, which are essential for microtubule formation and stability (UniProt Q15813). TBCE acts as one of five tubulin-specific chaperones (A-E) that capture and fold tubulin monomers into functional heterodimers (PubMed: 10436023). Mutations in the TBCE gene lead to a deficiency in functional protein, resulting in impaired microtubule assembly and severe developmental disorders, most notably Sanjad-Sakati syndrome (SSS) and Kenny-Caffey syndrome type 1 (KCS1) (OMIM: 604933). These conditions are characterized by permanent hypoparathyroidism, extreme growth failure, and distinct dysmorphic features (NCBI Gene: 6905). While there are currently no approved pharmacological agents that directly target TBCE mRNA or protein, the mRNA is a potential candidate for replacement therapies aimed at restoring chaperone function in affected patients. Research in this area focuses on using mRNA-based delivery systems or gene therapy to mitigate the cytoskeletal defects and endocrine deficiencies associated with TBCE loss-of-function. Overexpression or dysregulation of TBCE has also been implicated in certain cancers, suggesting its role in maintaining the microtubule network is vital for cellular proliferation (PubMed: 26451371).
Restoration of functional protein levels via mRNA replacement or gene therapy to facilitate tubulin heterodimer assembly.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tubulin-specific chaperone E (TBCE) (TBCE).